Reuters logo
a year ago
BRIEF-Gilead Sciences - European Commission grants marketing authorization for Truvada
August 22, 2016 / 4:03 PM / a year ago

BRIEF-Gilead Sciences - European Commission grants marketing authorization for Truvada

Aug 22 (Reuters) - Gilead Sciences Inc

* European Commission grants marketing authorization for Gilead's once-daily Truvada for reducing the risk of sexually acquired HIV-1

* Truvada is also authorized for prep in Australia, Canada, Kenya, Peru, South Africa and United States Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below